Kranzler HR - Search Results

1

Screening for health behaviors in ambulatory clinical settings: does smoking status predict hazardous drinking?

Kranzler HR, Amin H, Cooney NL, Cooney JL, Burleson JA, Petry N, Oncken C. Kranzler HR, et al. Addict Behav. 2002 Sep-Oct;27(5):737-49. doi: 10.1016/s0306-4603(01)00206-4. Addict Behav. 2002. PMID: 12201381

2

Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures.

Babor TF, Kranzler HR, Lauerman RJ. Babor TF, et al. Among authors: kranzler hr. Addict Behav. 1989;14(2):139-57. doi: 10.1016/0306-4603(89)90043-9. Addict Behav. 1989. PMID: 2728952

3

Alcoholism: clinical implications of recent research.

Meyer RE, Kranzler HR. Meyer RE, et al. Among authors: kranzler hr. J Clin Psychiatry. 1988 Sep;49 Suppl:8-12. J Clin Psychiatry. 1988. PMID: 3047109 Review.

4

Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?

Kranzler HR, Kadden RM, Burleson JA, Babor TF, Apter A, Rounsaville BJ. Kranzler HR, et al. Compr Psychiatry. 1995 Jul-Aug;36(4):278-88. doi: 10.1016/s0010-440x(95)90073-x. Compr Psychiatry. 1995. PMID: 7554872 Free article.

5

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.

Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N. Kranzler HR, et al. Am J Psychiatry. 1995 Mar;152(3):391-7. doi: 10.1176/ajp.152.3.391. Am J Psychiatry. 1995. PMID: 7864265 Clinical Trial.

6

Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.

Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS. Krystal JH, et al. Among authors: kranzler hr. Arch Gen Psychiatry. 1994 Nov;51(11):898-911. doi: 10.1001/archpsyc.1994.03950110058008. Arch Gen Psychiatry. 1994. PMID: 7944878 Clinical Trial.

7

Buspirone treatment of anxious alcoholics. A placebo-controlled trial.

Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, Bohn MJ. Kranzler HR, et al. Arch Gen Psychiatry. 1994 Sep;51(9):720-31. doi: 10.1001/archpsyc.1994.03950090052008. Arch Gen Psychiatry. 1994. PMID: 8080349 Clinical Trial.

8

Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.

Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS. Krystal JH, et al. Among authors: kranzler hr. Am J Psychiatry. 1996 Jan;153(1):83-92. doi: 10.1176/ajp.153.1.83. Am J Psychiatry. 1996. PMID: 8540598 Clinical Trial.

9

Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics.

Kranzler HR, Burleson JA, Brown J, Babor TF. Kranzler HR, et al. Alcohol Clin Exp Res. 1996 Dec;20(9):1534-41. doi: 10.1111/j.1530-0277.1996.tb01696.x. Alcohol Clin Exp Res. 1996. PMID: 8986200 Clinical Trial.

10

Utility of the AUDIT for identification of hazardous or harmful drinking in drug-dependent patients.

Skipsey K, Burleson JA, Kranzler HR. Skipsey K, et al. Among authors: kranzler hr. Drug Alcohol Depend. 1997 May 2;45(3):157-63. doi: 10.1016/s0376-8716(97)01353-7. Drug Alcohol Depend. 1997. PMID: 9179517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

661 results

Search Page

Filters